In a mouse model of Alzheimer’s disease, miR-21 and miR-181c effectively reduced amyloid-β accumulation and increased synaptic protein expression and miR-21 levels in the brains of APP/PS1 mice (Cui et al., 2018). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.